Will 2018 be the year of biotech M&A?

TMCM&A, Medical Device

We are just a month into 2018 and the biotech sector is already seeing a significant pickup in merger and acquisition (M&A) deals.   In just the past 30 days, there has been already $27.5 billion USD in deals within the biotech sector.  Highlights include Sanofi’s acquisition of Bioverativ, Celgene’s buyout of Juno Therapeutics, and Takeda Pharmaceutical buying TiGenix. M&A becomes … Read More

M&A – Who owns legacy data?

TMCM&A, Medical Device, Pharmaceuticals

M&A is the new normal for Life Science companies, driving innovation and growth; the capability to successfully integrate or divest businesses is a major source of competitive advantage. The industry has seen major acquisitions in recent years, with the Top 20 transaction volumes between $10 and $70 billion USD. When looking at these acquisitions in more detail, we see different … Read More